Neurizon Therapeutics Ltd
OTC:NUZTF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neurizon Therapeutics Ltd
OTC:NUZTF
|
AU |
|
D
|
Danaher Corp
F:DAP
|
US |
|
R
|
Rocky Brands Inc
F:RCK
|
US |
|
I
|
Interpublic Group of Companies Inc
F:IPG
|
US |
|
R
|
Raimon Land PCL
SET:RML
|
TH |
|
H
|
Hexindo Adiperkasa Tbk PT
F:HX1A
|
ID |
|
B
|
BEC World PCL
SET:BEC
|
TH |
|
Complii Fintech Solutions Ltd
ASX:CF1
|
AU |
|
Webuild SpA
MIL:WBD
|
IT |
|
L
|
LH Shopping Centers Leasehold Real Estate Investment Trust
SET:LHSC
|
TH |
|
Agereh Technologies Inc
XTSX:AUTO
|
CA |
|
S
|
Strategic Energy Resources Ltd
F:EB8
|
AU |
|
A
|
Aurizon Holdings Ltd
F:QRL
|
AU |
|
C
|
Costar Group Inc
XMUN:RLG
|
US |
|
M
|
Moatech Co Ltd
KOSDAQ:033200
|
KR |
|
E
|
Enento Group Oyj
F:AKA
|
FI |
|
B
|
BISI International Tbk PT
SWB:4FM
|
ID |
|
R
|
RS PCL
SET:RS
|
TH |
|
P
|
Panasonic Holdings Corp
XMUN:MAT1
|
JP |
|
Inflection Point Acquisition Corp V
NASDAQ:IPEX
|
US |
|
A
|
AIB Group PLC
DUS:A5G
|
IE |
Bankruptcy Probability
Neurizon Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Neurizon Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Neurizon Therapeutics Ltd
ASX:NUZ
|
64.1m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
610B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
365.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
358.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
239.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
193B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
285.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
167.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Neurizon Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Neurizon Therapeutics Ltd has total debt of 3.3m AUD. This includes both short-term (3.3m AUD) and long-term (0 AUD) debt.
You can find a full breakdown on its Balance Sheet.